Dispatch Biotherapeutics
PrivateLast Round
Series A
Jul 23, 2025
Total Funding Raised
$216M
Company Overview
Dispatch Biotherapeutics is a biotechnology company focused on developing cancer therapies that leverage the immune system to effectively eliminate tumors and prevent relapse, providing patients with improved treatment options.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dispatch Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Dispatch Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 23, 2025 |
Key People
Founding team and executive leadership
Dispatch Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pennsylvania | Series A |
| Stanford University | Series A |
| Parker Institute for Cancer Immunotherapy | Series A |
| ARCH Venture Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Collaboration with University of Pennsylvania and other leading institutions.
- Jan 16, 2026
Partnering with CARsgen Therapeutics to develop CAR-T cell therapies.
Dispatch Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dispatch Biotherapeutics's valuation, stock price, and market status.
